Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.66 USD | +3.54% | -6.97% | -24.75% |
05-10 | NetScientific says PDS Biotech's Versamune meets endpoints | AN |
05-10 | PDS Biotechnology Says Head, Neck Cancer Therapy Met Main Goal in Mid-Stage Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.75% | 130M | |
+5.92% | 111B | |
+11.69% | 106B | |
-12.67% | 22.24B | |
+0.06% | 21.25B | |
-4.83% | 18.97B | |
-35.21% | 18.52B | |
-10.55% | 16.81B | |
+37.76% | 12.54B | |
-24.71% | 8.09B |
- Stock Market
- Equities
- PDSB Stock
- News PDS Biotechnology Corporation
- HC Wainwright Adjusts Price Target on PDS Biotechnology to $21 From $15, Maintains Buy Rating